Author's posts
Community Health Network to bolster security with airport tech company
Indianapolis-based Community Health Network is partnering with CLEAR, the company known for developing biometric ID checks for airports, in a bid to enhance security.
Northwestern names new oncology chief
Chicago-based Northwestern Medicine has named Hidayatullah Munshi, MD, chief of the hematology and oncology division in the Department of Medicine at the Feinberg School of Medicine.
Mark Cuban to employers: Save millions with 1 move
Large companies can save millions of dollars by addressing one common misconception about health insurance plans, according to billionaire entrepreneur Mark Cuban.
Democrats pitch permanent ACA subsidies
U.S. Senators Jeanne Shaheen (D-N.H.) and Tammy Baldwin (D-Wis.) have introduced the Health Care Affordability Act, which aims to permanently extend the Affordable Care Act’s enhanced premium tax credits for marketplace coverage.
How this Montana hospital went from a 2.5% to 10% projected margin
Since Julie Leonard became CFO of Libby, Mont.-based Cabinet Peaks Medical Center in January, the 25-bed critical access hospital has seen skyrocketing financial improvement, rising from a projected 2.5% margin by the end of its fiscal year in March to…
WVU Medicine taps COO of 2 hospitals
Leslie Lawson has been named COO of South Charleston, W.Va.-based WVU Medicine Thomas Hospitals, effective Sept. 30.
Mount Sinai, Noom partner to enhance weight loss care
A new collaboration between New York City-based Mount Sinai Health System and digital platform Noom will provide patients access to on-demand tools and resources that support their weight loss goals.
HHS calls for stricter oversight of remote patient monitoring
HHS is calling for increased oversight for remote patient monitoring as its use within Medicare has increased in recent years.
Tennessee system taps new CEO
Jackson-based West Tennessee Healthcare has promoted its COO to the top leadership role following the death of President and CEO James “JR” Ross, BSN.
FDA challenges broad use of PD-1 inhibitors in stomach cancer patients
The FDA is reassessing the approval of immune checkpoint inhibitors for treating advanced HER2-negative gastric adenocarcinoma, questioning their broad application regardless of patients’ PD-L1 expression levels.
